摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(N-methyl-1H-indol-3-yl)-N-[2-(4-methoxyphenyl)-2-oxoethyl]acetamide | 1038914-95-2

中文名称
——
中文别名
——
英文名称
2-(N-methyl-1H-indol-3-yl)-N-[2-(4-methoxyphenyl)-2-oxoethyl]acetamide
英文别名
N-[2-(4-methoxyphenyl)-2-oxoethyl]-2-(1-methylindol-3-yl)acetamide
2-(N-methyl-1H-indol-3-yl)-N-[2-(4-methoxyphenyl)-2-oxoethyl]acetamide化学式
CAS
1038914-95-2
化学式
C20H20N2O3
mdl
——
分子量
336.39
InChiKey
OPVNDMTWWWBENB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    60.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(N-methyl-1H-indol-3-yl)-N-[2-(4-methoxyphenyl)-2-oxoethyl]acetamidepotassium tert-butylate 作用下, 以 四氢呋喃 为溶剂, 反应 0.25h, 以56%的产率得到3-(N-methyl-1H-indol-3-yl)-4-(4-methoxyphenyl)-1,5-dihydro-2H-pyrrole-2-one
    参考文献:
    名称:
    Design, Synthesis, and Biological Evaluation of Novel 3-Aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as Vascular Endothelial Growth Factor Receptor (VEGF-R) Inhibitors
    摘要:
    In this study we report on the design, synthesis, and biological evaluation of pyrrole-2-one 2 to be a highly potent VEGF-R2/3 inhibitor with IC50 of 31/37 nM. The novel 3,4-diaryl-2H-pyrrole-2-ones were designed on the basis of the modeled binding mode of the corresponding 1H-pyrrole-2,5-dione (maleimide) VEGFR2/3 inhibitor I indicating two H-bond ligand-protein interactions in the ATP pocket for the amide 2 but not for the isomer 3. Flexible synthetic routes to 3,4-diaxyl-2H-pyrrole-2-ones and structure - activity relationships for the compounds in a panel of 24 therapeutically relevant protein kinases (IC50 values) are presented. Accordingly to the in vitro data, compounds 1 and 2 were found to possess highly potent antiangiogenic activities in the cellular HLMEC sprouting assay and also slightly induced apoptosis in HDMECs whereas 3 was determined to be significantly less active. Hence, the pyrrole-2-one moiety was dissected from the corresponding maleimide protein kinase inhibitor as a suitable key pharmacophore.
    DOI:
    10.1021/jm8001185
  • 作为产物:
    描述:
    1-(1-methyl-1H-indol-3-yl)propan-2-one2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐1-羟基苯并三唑N,N'-二环己基碳二亚胺N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 65.0h, 以88%的产率得到2-(N-methyl-1H-indol-3-yl)-N-[2-(4-methoxyphenyl)-2-oxoethyl]acetamide
    参考文献:
    名称:
    Design, Synthesis, and Biological Evaluation of Novel 3-Aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as Vascular Endothelial Growth Factor Receptor (VEGF-R) Inhibitors
    摘要:
    In this study we report on the design, synthesis, and biological evaluation of pyrrole-2-one 2 to be a highly potent VEGF-R2/3 inhibitor with IC50 of 31/37 nM. The novel 3,4-diaryl-2H-pyrrole-2-ones were designed on the basis of the modeled binding mode of the corresponding 1H-pyrrole-2,5-dione (maleimide) VEGFR2/3 inhibitor I indicating two H-bond ligand-protein interactions in the ATP pocket for the amide 2 but not for the isomer 3. Flexible synthetic routes to 3,4-diaxyl-2H-pyrrole-2-ones and structure - activity relationships for the compounds in a panel of 24 therapeutically relevant protein kinases (IC50 values) are presented. Accordingly to the in vitro data, compounds 1 and 2 were found to possess highly potent antiangiogenic activities in the cellular HLMEC sprouting assay and also slightly induced apoptosis in HDMECs whereas 3 was determined to be significantly less active. Hence, the pyrrole-2-one moiety was dissected from the corresponding maleimide protein kinase inhibitor as a suitable key pharmacophore.
    DOI:
    10.1021/jm8001185
点击查看最新优质反应信息

文献信息

  • [DE] CYCLISCHE AMIDVERBINDUNGEN, VERFAHREN ZU DEREN HERSTELLUNG UND IHRE VERWENDUNG<br/>[EN] CYCLIC AMIDE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF<br/>[FR] COMPOSÉS D'AMIDES CYCLIQUES, LEUR PROCÉDÉ DE PRODUCTION ET LEUR UTILISATION
    申请人:UNIV EBERHARD KARLS
    公开号:WO2009010542A1
    公开(公告)日:2009-01-22
    Die Erfindung betrifft cyclische Amidverbindungen der allgemeinen Formel (I), worin R1 und R2 in Anspruch 1 definiert sind. Die Erfindung betrifft ferner das Verfahren zur Herstellung der Verbindungen der Formel (I), pharmazeutische Mittel enthaltend wenigstens eine dieser Verbindungen sowie deren Verwendung zur Angiogenesehemmung und zur Prävention und/oder Therapie von mit Angiogenese assoziierten Krankheiten, insbesondere Krebserkrankungen.
  • Design, Synthesis, and Biological Evaluation of Novel 3-Aryl-4-(1<i>H</i>-indole-3yl)-1,5-dihydro-2<i>H</i>-pyrrole-2-ones as Vascular Endothelial Growth Factor Receptor (VEGF-R) Inhibitors
    作者:Christian Peifer、Roland Selig、Katrin Kinkel、Dimitri Ott、Frank Totzke、Christoph Schächtele、Regina Heidenreich、Martin Röcken、Dieter Schollmeyer、Stefan Laufer
    DOI:10.1021/jm8001185
    日期:2008.7
    In this study we report on the design, synthesis, and biological evaluation of pyrrole-2-one 2 to be a highly potent VEGF-R2/3 inhibitor with IC50 of 31/37 nM. The novel 3,4-diaryl-2H-pyrrole-2-ones were designed on the basis of the modeled binding mode of the corresponding 1H-pyrrole-2,5-dione (maleimide) VEGFR2/3 inhibitor I indicating two H-bond ligand-protein interactions in the ATP pocket for the amide 2 but not for the isomer 3. Flexible synthetic routes to 3,4-diaxyl-2H-pyrrole-2-ones and structure - activity relationships for the compounds in a panel of 24 therapeutically relevant protein kinases (IC50 values) are presented. Accordingly to the in vitro data, compounds 1 and 2 were found to possess highly potent antiangiogenic activities in the cellular HLMEC sprouting assay and also slightly induced apoptosis in HDMECs whereas 3 was determined to be significantly less active. Hence, the pyrrole-2-one moiety was dissected from the corresponding maleimide protein kinase inhibitor as a suitable key pharmacophore.
查看更多